Pulmicort Respules

Proteinuria, Asthma, Itching + 16 more

Treatment

20 Active Studies for Pulmicort Respules

Treatment for

Proteinuria

What is Pulmicort Respules

Budesonide

The Generic name of this drug

Treatment Summary

Budesonide is a steroid medication used to reduce inflammation in the lungs, intestines, and other areas of the body. It is commonly prescribed to treat asthma, COPD, Crohn's disease, and ulcerative colitis. Budesonide was approved by the FDA in 1994.

Rhinocort

is the brand name

image of different drug pills on a surface

Pulmicort Respules Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rhinocort

Budesonide

1994

134

Effectiveness

How Pulmicort Respules Affects Patients

Budesonide is a medication used to reduce inflammation caused by certain digestive and respiratory conditions. The amount of budesonide taken varies from person to person, making it a very safe drug. However, it can cause an increase in cortisol levels and suppress the adrenal axis, so patients must be careful to use it as prescribed.

How Pulmicort Respules works in the body

Corticosteroids work quickly to reduce inflammation by narrowing blood vessels and stopping white blood cells from traveling to inflamed areas. They also work on a genetic level to stop inflammation from happening in the first place. Corticosteroids stop cells from dying and stop chemicals from forming that cause inflammation. Lower doses are good for reducing inflammation, while higher doses can suppress your immune system. If you take high doses for a long time, it can affect the levels of sodium and potassium in your body.

When to interrupt dosage

The extent of Pulmicort Respules is contingent upon the diagnosed condition, such as Vasomotor Rhinitis, Crohn's Disease and Chronic Obstructive Pulmonary Disease (COPD). The amount of dosage also changes, depending on the mode of delivery (e.g. Enema; Kit; Tablet - Rectal or Respiratory (inhalation)) mentioned in the table below.

Condition

Dosage

Administration

Proteinuria

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Oral, Spray, metered - Nasal, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered, Powder, metered - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Capsule, delayed release, Patch - Cutaneous, Patch

Itching

Rhinitis, Vasomotor

Nasal Polyps

Eosinophilic Esophagitis

Crohn Disease

Asthma

Skin Diseases

maintenance therapy

Chronic Obstructive Pulmonary Disease

Acute Coryza

Ulcerative Colitis

Colitis, Collagenous

Crohn's Disease

Nasal Congestion

Hypersensitivity

IGA Glomerulonephritis

Sinusitis

Crohn Disease

Warnings

Pulmicort Respules Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

There are 20 known major drug interactions with Pulmicort Respules.

Common Pulmicort Respules Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Budesonide.

Abetimus

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abetimus.

Pulmicort Respules Toxicity & Overdose Risk

Taking too much corticosteroid medication over a long period of time can cause increased levels of the hormone and suppress the body’s natural production. In case of an overdose, the dosage should be reduced. 200mg of the drug is fatal for female mice and 400mg for male mice.

image of a doctor in a lab doing drug, clinical research

Pulmicort Respules Novel Uses: Which Conditions Have a Clinical Trial Featuring Pulmicort Respules?

516 active studies are being conducted to assess the potential of Pulmicort Respules for treating Chronic Obstructive Pulmonary Disease (COPD), Ulcerative Colitis and Allergic Reactions.

Condition

Clinical Trials

Trial Phases

Asthma

84 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Itching

3 Actively Recruiting

Phase 3, Not Applicable

Chronic Obstructive Pulmonary Disease

70 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Proteinuria

5 Actively Recruiting

Phase 2, Phase 3, Phase 4, Phase 1

IGA Glomerulonephritis

0 Actively Recruiting

Ulcerative Colitis

17 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable, Phase 4

Sinusitis

0 Actively Recruiting

Crohn's Disease

52 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4, Early Phase 1

Hypersensitivity

1 Actively Recruiting

Phase 4

Colitis, Collagenous

0 Actively Recruiting

Skin Diseases

0 Actively Recruiting

maintenance therapy

0 Actively Recruiting

Rhinitis, Vasomotor

1 Actively Recruiting

Not Applicable

Eosinophilic Esophagitis

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Polyps

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Pulmicort Respules Reviews: What are patients saying about Pulmicort Respules?

Patient Review

9/3/2011

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

Although this medicine helped me use my rescue inhaler and nebulizer less, the side effects were really terrible. After taking two puffs each day for a couple months, my vision started getting blurry. My mood swings also got worse; I would blame them on PMS but they would last much longer than usual. I also gained weight without changing my habits, which was really confusing (I was previously taking prednisone and Advair).

Patient Review

6/15/2014

Pulmicort Respules for Asthma

Pulmicort has worked well for me in the long term to keep my asthma manageable, though it comes with some significant side effects like a dry mouth, easy bruising, and increased susceptibility to infection and illness.

Patient Review

5/14/2016

Pulmicort Respules for Asthma

Pulmicort does an excellent job of coating my lungs and keeping my airways from feeling irritated. After taking it, I feel completely normal and my symptoms are well controlled.

Patient Review

9/9/2013

Pulmicort Respules for Asthma Prevention

I use this medication in my nebulizer twice a day, and it has helped me a lot.

Patient Review

9/3/2011

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

Although this medicine helped me to use my rescue inhaler and nebulizer less, the side effects were really tough to deal with. After a few months of taking two puffs each day, my vision started getting blurry and I would have terrible mood swings that lasted for weeks. I also gained weight without changing my diet or exercise habits.

Patient Review

6/15/2014

Pulmicort Respules for Asthma

Pulmicort has been a godsend for me, keeping my asthma at bay where other drugs have failed. The side effects are harsh, but I'll take them any day over the alternative of regular asthma attacks.

Patient Review

9/18/2011

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

I found it much easier to breathe after taking this medication. It also seemed to help open up my lungs and provided fast-acting relief.

Patient Review

5/14/2016

Pulmicort Respules for Asthma

I found that Pulmicort really helped to soothe my lungs and control my symptoms. It's great to be able to feel normal again.

Patient Review

1/31/2011

Pulmicort Respules for Asthma

I've only been taking this medication for a short time, but I already think it's helping me.

Patient Review

9/9/2013

Pulmicort Respules for Asthma Prevention

I use this medication in my nebulizer twice a day, and it's really helped me breathe better.

Patient Review

1/31/2011

Pulmicort Respules for Asthma

I've only been taking this medication for a short while, but I already notice an improvement.

Patient Review

9/18/2011

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

This medication quickly and effectively opens up my lungs, making it easier to breathe. I don't experience any shaking or jitters, which is great.

4.3

Patient Review

6/24/2010

Pulmicort Respules for Asthma

I was unable to wean off of oral steroids, so my allergist increased the dose. Unfortunately, this caused me to have severe bronchial spasms and difficulty breathing. I also experienced throat swelling, lip and eye swelling, chest pain, stomach ache, skin rash, and severe itching. The mood swings and crying were also very difficult to deal with. Overall, I would not recommend this medication.

4.3

Patient Review

6/24/2010

Pulmicort Respules for Asthma

I was unable to wean myself off oral steroids, so my allegist increased the dose. Unfortunately, this resulted in severe bronchial spasms, difficulty breathing, throat swelling, lips and eye swelling, chest pain and stomach ache. Additionally, I experienced skin rash, severe itching and mood swings. Overall, I would not recommend this medication to others.

Patient Review

7/8/2010

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

My son took this medication when he was younger and it really didn't seem to help him that much. In fact, he seemed to swell up and retain fluid more often, and he was sick all of the time. We stopped giving it to him and now his asthma only flares up every once in a while.

Patient Review

7/8/2010

Pulmicort Respules for Severe Chronic Obstructed Lung Disease

My son took this medication when he was younger and it really seemed to help his asthma. However, the side effects were pretty severe; he retained fluid and was constantly sick. We stopped giving it to him and now his asthma only flares up every once in a while.

Patient Review

12/21/2010

Pulmicort Respules for Asthma

This didn't work well for me.

Patient Review

12/21/2010

Pulmicort Respules for Asthma

I wasn't impressed with this treatment.

2.7

Patient Review

3/19/2011

Pulmicort Respules for Asthma

My blood pressure increased while I was on this medication, and returned to normal when I stopped taking it. I asked my doctor if we could try something else, but he insisted that I keep using the Pulmicort. So, for now, I'll only use it in short bursts when I'm desperate for relief.

2.7

Patient Review

3/19/2011

Pulmicort Respules for Asthma

My blood pressure increased while on this medication, but returned to normal when I stopped taking it. When asking my doctor for alternatives, he told me to keep using the Pulmicort. I only use it sporadically now whenever I'm desperate for relief.

2.3

Patient Review

3/7/2010

Pulmicort Respules for Asthma Prevention

2.3

Patient Review

3/7/2010

Pulmicort Respules for Asthma Prevention

Patient Review

3/5/2010

Pulmicort Respules for Asthma Prevention

Patient Review

3/5/2010

Pulmicort Respules for Asthma Prevention

1.7

Patient Review

3/23/2010

Pulmicort Respules for Asthma Prevention

Pulmicort did the opposite of what it was supposed to do for me. After two weeks of use, I ended up in the hospital with worse breathing problems. My doctor said it was just a coincidence, but I strongly disagree. I switched to Advair and have been doing much better ever since.

1.7

Patient Review

3/23/2010

Pulmicort Respules for Asthma Prevention

I was on Pulmicort for two weeks, and my breathing got worse and worse until I ended up in the hospital. My doctor said it was just chance that it worked out that way, but I have to agree to disagree with her on that one. I switched to Advair, despite the warnings, and am doing better than I have in years.

1.3

Patient Review

6/4/2010

Pulmicort Respules for Asthma

My granddaughter has been on this medication for over a year now, and we've seen very little improvement. If anything, she seems to be sick more often than before. We have to take her to the doctor every other week and use more albuterol than pulmicort. I would not recommend this medication to anyone.

1.3

Patient Review

6/4/2010

Pulmicort Respules for Asthma

My granddaughter has been on this medication for over a year now, and we have to see the doctor every other week. We use more albuterol than pulmicort, and she is always put on prednisone along with the albuterol. This medication is not controlling her asthma at all.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about pulmicort respules

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Pulmicort Respules used for?

"Asthma treatment with PULMICORT RESPULES, an inhaled corticosteroid (ICS), can improve asthma symptoms in children ages 12 months to 8 years."

Answered by AI

Is Pulmicort good for cough?

"Budesonide is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma. The powder form of Budesonide for oral inhalation (Pulmicort Flexhaler) is used in adults and children 6 years of age and older."

Answered by AI

Is Pulmicort Respules a steroid?

"Pulmicort Respules is a steroid that helps prevent asthma attacks. It is for use in children 12 months to 8 years old. Pulmicort Flexhaler is for use in adults and children at least 6 years old. Budesonide may also be used for purposes not listed in this medication guide."

Answered by AI

How do you Nebulize with Pulmicort?

"To administer Pulmicort Respules, you should use a jet nebuliser equipped with either a mouthpiece or a face mask. The nebuliser should be connected to an air compressor with a flow rate of 6-8 L/min, and the fill volume should be 2-4 ml."

Answered by AI

Clinical Trials for Pulmicort Respules

Have you considered Pulmicort Respules clinical trials?

We made a collection of clinical trials featuring Pulmicort Respules, we think they might fit your search criteria.

Have you considered Pulmicort Respules clinical trials?

We made a collection of clinical trials featuring Pulmicort Respules, we think they might fit your search criteria.

Image of Stanford University in Stanford, United States.

MoblO2 for Chronic Lung Diseases

18+

All Sexes

Stanford, CA

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of the following: 1) that it will limit desaturation events and combat breathlessness, thus preventing the frustratingly slow pace and numerous rest breaks patients are forced to adopt while doing even simple tasks; 2) that it will allow patients to be more active physically (perhaps increase their ability to exercise) and socially (perhaps leave the home more often); 3) that it will stave off putative complications of hypoxemia (e.g., cognitive dysfunction, pulmonary hypertension) and 4) that it will improve health-related quality of life (HRQL). However, despite the rationale for O2, and prescribers' good intentions, patients generally view O2 with frustration and fear - it threatens their HRQL, which is already impaired by having a condition that imposes itself on every aspect of their lives. Nasal cannulas and delivery devices call unwanted attention to patients when they are out in public. O2 users feel stigmatized and are often viewed as "smokers who get what they deserve, even if they never smoked a day in their lives" - or as disabled, sick or even infectious. O2 steals patients' independence, forcing them to plan their lives around it. The anxiety that patients and their caregivers experience around running out of oxygen, or not getting enough, immobilizes them and restricts participation in activities outside of the home. O2 disrupts the home environment, adding stress, and creating a burden for patients' caregiver-loved-ones who are often saddled with the responsibility of ensuring adequate equipment and supply of O2, and O2 is a constant reminder to patients they are living with a condition that could shorten their lives. O2 delivery equipment is typically heavy, unwieldy and intimidating. Different recommendations (e.g., insurance companies use 88% as a cut-off for SpO2, while many practitioners focus on 90%) make it confusing for patients, which almost certainly affects adherence. O2-requiringpatients are starving for things that can make their lives easier. An auto-adjusting O2 delivery device - one that automatically delivers the correct amount of O2 to maintain blood oxygen at desired, pre-set levels - would alleviate the need for patients to constantly (incessantly for many) monitor their peripheral oxygen saturation (SpO2) and adjust O2flow to meet the demands as exertion levels vary . The MoblO2 device is a battery-operated, light-weight, closed-loop O2 delivery device that houses a regulator (which attaches to compressed gas O2 tanks) and adjusts O2 flow to meet a pre-set blood oxygen level. A pulse oximeter is worn on the ear and transmits via Bluetooth to the device, which adjusts an internal valve to control flow on a second-to-second basis. The user sets the dial to the highest flow of O2 needed to meet the demands of activities they might perform (up to 15 liters per minute), and the device adjusts flow, up to the pre-set level to maintain SpO2 at a preset level (e.g., \> 90%). To conserve O2 supply in the tank - and to avoid over-oxygenation (which could be problematic for a small percentage of patients with the most severe COPD) - the MoblO2 begins to limit O2 flow at a SpO2 of 93%. The device can be manually over-ridden by the user, and should the battery run out - or the device fail for some unforeseen reason - the default position is valve open, so the users receive whatever flow of oxygen has been set on the dial. Given the substantial burdens of O2 on patients and their families, the hassles patients describe with having to monitor their SpO2 and repeatedly adjust the flow of O2 to meet their needs, patients and experts around the world have called for improvements in O2 delivery equipment. The MoblO2 is just such a remarkable improvement and a giant step forward in helping to ease the burdens of O2 on patients who require it. The purpose of this study is to investigate the effects of the MoblO2 O2 delivery device on a range of outcomes, including physical activity, amount (liters) O2 use; maintenance of adequate SpO2 levels; patient reported outcomes including symptoms, HRQL and satisfaction with the MoblO2 O2 device.

Waitlist Available

Has No Placebo

Stanford University

Jeff Swigris, DO, MS

Minnesota Health Solutions